GlycoSeLect Private

GlycoSeLect is a specialized organization that focuses on the development and production of Recombinant Prokaryotic Lectins (RPLs). These RPLs are bioaffinity proteins that enable efficient detection, analysis, and isolation of glycosylated biomolecules. The organization's main goal is to provide enhanced tools for the analysis and selective purification of glycosylated biomolecules in various industries, including biopharmaceuticals, vaccines, cosmetics, and biomedical diagnostics. GlycoSeLect's RPLs offer significant advantages over existing lectin products, such as simplified and cost-effective production, high purity, consistent performance, and genetically enhanced glycan binding properties. With scalable production capabilities, GlycoSeLect's RPLs can be utilized for both analytical and production-scale applications.

Industry: PharmTech
Headquarters: Ireland
Founded Date: 2013-10-01 00:00:00
Employee Number: 1—10